Loading clinical trials...
Loading clinical trials...
Preferences Of Patients And Oncologists For The Characteristics Of The Treatment For RCC In Spain And Portugal
The purpose of this observational study is to determine patients' and professionals' preferences for the characteristics (attributes) of the treatment for Renal cell carcinoma (RCC) in Spain and Portugal.
This study uses a literature review, qualitative (focus groups) and quantitative methods (discrete-choice experiment, DCE) to determine renal cell carcinoma (RCC) participants and oncologists' preferences. In this clinical trial, the study team will develop a survey consisting of comparisons of hypothetical treatment profiles (scenarios). Scenarios are presented to participants, and each participant chooses the most preferable.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
Local Institution
Castellon, Spain
Start Date
August 5, 2019
Primary Completion Date
July 13, 2020
Completion Date
July 13, 2020
Last Updated
December 23, 2021
105
ACTUAL participants
Lead Sponsor
Bristol-Myers Squibb
NCT07485114
NCT06391099
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions